BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:08 pm Sale | 2025-09-30 | 13G | FORTE BIOSCIENCES INC FBRX | BIOTECHNOLOGY VALUE FUND L P | 65,350 0.500% | -578,272 (-89.85%) | Filing |
| 2025-02-14 4:11 pm Purchase | 2024-12-31 | 13G | FORTE BIOSCIENCES INC FBRX | BIOTECHNOLOGY VALUE FUND L P | 643,622 9.990% | 524,338 (+439.57%) | Filing |